StockClub
NKTRNektar Therapeutics$ --
Nektar Therapeutics

Nektar Therapeutics

NKTR

$ -

-

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

analyticsIncome Statement Summary

FY2025 Full YearUpdated: 12/31/2025

Revenue

attach_money
55M USD
YoY -43.9%

Operating Income

bar_chart
-131M USD
YoY -24.3%

Net Income

verified
-164M USD
YoY -37.9%

EPS

pie_chart
-9.73USD
YoY -12.1%

Quarterly Performance

Quarterly revenue and net income trend

RevenueOperating IncomeNet Income
No quarterly data available

Full-Year Progress

FY2025
Net Income Progress100%On Track
Revenue Progress55.2M
Revenue Forecast43.6M
Net Income Progress-164.1M
Net Income Forecast-164.1M

Income Statement Details

Item
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
Cost of revenue
Gross profit
55
0
55
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
117
0
69
186
-131
Interest expense
Income before tax
Income tax expense
Net income
26
-164
-0
-164

Unlock Long-Term Income Statement Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.